Literature DB >> 30165237

Recidivism Is the Leading Cause of Death Among Intravenous Drug Users Who Underwent Cardiac Surgery for Infective Endocarditis.

Max Jordan Nguemeni Tiako1, Makoto Mori1, Syed Usman Bin Mahmood1, Kayoko Shioda2, Abeel Mangi1, James Yun1, Arnar Geirsson3.   

Abstract

The proportional incidence of intravenous drug use (IVDU)-associated infective endocarditis (IE) cases requiring surgery has increased significantly, mirroring the national opioid crisis. Recidivism is common but its impact on postoperative outcomes is unclear. We aimed to evaluate short- and mid-term postoperative outcomes associated with recidivism in this population. We retrospectively reviewed 180 consecutive patients (54 IVDU and 126 non-IVDU) surgically treated for IE from 2011 to 2016. The institutional database was linked to the Connecticut Department of Public Health Death Index to capture statewide long-term mortality and causes of death. Regression models were fitted to evaluate the association between IVDU status and perioperative adverse events, mid-term survival, and causes of death. IVDU patients were younger and had fewer comorbidities. Diabetes, hypertension, peripheral vascular disease, and previous coronary artery bypass graft were less frequently present in IVDU patients compared to non-IVDU patients (P < 0.05 for all). The Society of Thoracic Surgeons mortality prediction score for IE was lower in IVDU patients (22.9 vs 33.6, P < 0.001). IVDU was associated with a significantly increased risk of perioperative adverse events (odds ratio 2.88, 95% confidence interval 1.02-8.12) and increased risk of mid-term mortality (hazard ratio 2.2, 95% confidence interval 1.04-4.78, P = 0.04). The leading cause of death in IVDU patients was related to recidivism whereas that of non-IVDU patients was related to chronic conditions. IVDU patients who underwent cardiac surgery for IE experienced higher risks of perioperative adverse events and inferior mid-term survival compared to non-IVDU, despite being younger and having less comorbidities. Deaths in IVDU cohort were predominantly due to recidivism. Efforts to improve long-term outcome of patients presenting with IVDU IE should include drug addiction intervention and other strategies to reduce recidivism.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac surgery; Endocarditis; Opioid epidemic; Recidivism

Mesh:

Year:  2018        PMID: 30165237     DOI: 10.1053/j.semtcvs.2018.07.016

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN: 1043-0679


  15 in total

1.  Risk of reoperative valve surgery for endocarditis associated with drug use.

Authors:  Makoto Mori; Syed Usman Bin Mahmood; Asher J Schranz; Ibrahim Sultan; Andrea L Axtell; Nadeen Sarsour; William Hiesinger; Marko T Boskovski; Sameer Hirji; Tsuyoshi Kaneko; Joseph Woo; Paul Tang; Arminder S Jassar; Pavan Atluri; Bryan A Whitson; Thomas Gleason; Arnar Geirsson
Journal:  J Thorac Cardiovasc Surg       Date:  2019-07-10       Impact factor: 5.209

2.  The Evolving Burden of Drug Use Associated Infective Endocarditis in the United States.

Authors:  Arnar Geirsson; Asher Schranz; Oliver Jawitz; Makoto Mori; Liqi Feng; Brittany A Zwischenberger; Alexander Iribarne; Joseph Dearani; Gregory Rushing; Vinay Badhwar; Juan A Crestanello
Journal:  Ann Thorac Surg       Date:  2020-05-06       Impact factor: 4.330

3.  Impact of Substance Use Disorder on Midterm Mortality After Valve Surgery for Endocarditis.

Authors:  Alysse G Wurcel; Griffin Boll; Deirdre Burke; Rani Khetarpal; Patrick J Warner; Alice M Tang; Kenneth G Warner
Journal:  Ann Thorac Surg       Date:  2019-10-17       Impact factor: 4.330

4.  Expanding the Team: Optimizing the Multidisciplinary Management of Drug Use-Associated Infective Endocarditis.

Authors:  Matthew O'Donnell; Honora Englander; Luke Strnad; Castigliano M Bhamidipati; Evan Shalen; Patricio A Riquelme
Journal:  J Gen Intern Med       Date:  2022-01-11       Impact factor: 5.128

5.  Surgical treatment of infective endocarditis: Results in 831 patients from a single center.

Authors:  Arman Kilic; Lauren V Huckaby; Yeahwa Hong; Ibrahim Sultan; Edgar Aranda-Michel; Floyd Thoma; Yisi Wang; Forozan Navid; Thomas G Gleason
Journal:  J Card Surg       Date:  2020-08-25       Impact factor: 1.778

Review 6.  Infective Endocarditis in Persons Who Use Drugs: Epidemiology, Current Management, and Emerging Treatments.

Authors:  Asher Schranz; Joshua A Barocas
Journal:  Infect Dis Clin North Am       Date:  2020-09       Impact factor: 5.982

7.  A qualitative assessment of discharge against medical advice among patients hospitalized for injection-related bacterial infections in West Virginia.

Authors:  R A Pollini; C E Paquette; T Drvar; P Marshalek; M Ang-Rabanes; J Feinberg; M W Haut
Journal:  Int J Drug Policy       Date:  2021-03-23

8.  Comparing right- and left sided injection-drug related infective endocarditis.

Authors:  Allan Clarelin; Magnus Rasmussen; Lars Olaison; Sigurdur Ragnarsson
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

9.  Surgeons' re-operative valve replacement practices in patients with endocarditis due to drug use.

Authors:  Julie M Aultman; Oliwier Dziadkowiec; Dianne McCallister; Michael S Firstenberg
Journal:  Int J Crit Illn Inj Sci       Date:  2021-12-18

10.  Trends in Infective Endocarditis Hospitalizations, Characteristics, and Valve Operations in Patients With Opioid Use Disorders in the United States: 2005-2014.

Authors:  Makoto Mori; Kelly J Brown; Syed Usman Bin Mahmood; Arnar Geirsson; Abeel A Mangi
Journal:  J Am Heart Assoc       Date:  2020-03-15       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.